🇺🇸 FDA
Patent

US 12077502

Formulations of T-type calcium channel modulators and methods of use thereof

granted A61KA61K31/445A61K47/38

Quick answer

US patent 12077502 (Formulations of T-type calcium channel modulators and methods of use thereof) held by PRAXIS PRECISION MEDICINES, INC. expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PRAXIS PRECISION MEDICINES, INC.
Grant date
Tue Sep 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
35
CPC classes
A61K, A61K31/445, A61K47/38, A61K9/0053, A61K9/2009